Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Genomic Health Company Profile (NASDAQ:GHDX)

Consensus Ratings for Genomic Health (NASDAQ:GHDX) (?)
Ratings Breakdown: 2 Sell Rating(s), 3 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Hold (Score: 2.13)
Consensus Price Target: $31.80 (16.74% upside)

Current Analysts' Coverage Summary for Genomic Health (NASDAQ:GHDX)
Show:
DateFirmActionRatingPrice TargetActions
5/8/2015ZacksDowngradeHold -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015JMP SecuritiesLower Price TargetMarket Outperform$36.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Canaccord GenuityReiterated RatingHold$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014Wells Fargo & Co.Initiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/1/2014TheStreetDowngradeHold -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014Credit SuisseReiterated RatingNeutral$28.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014Bank of AmericaReiterated RatingBuy$28.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014JPMorgan Chase & Co.Reiterated RatingNeutral$29.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2014Jefferies GroupLower Price Target$33.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2013BMO Capital MarketsBoost Price TargetUnderperform$18.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2013Raymond JamesDowngradeMarket Perform -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/2/2013MLV & Co.Boost Price TargetHold$30.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2013Goldman SachsDowngradeNeutral -> Sell$27.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2013Leerink SwannReiterated RatingOutperform$41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2013 forward)